SLC22A2, solute carrier family 22 member 2, 6582

N. diseases: 98; N. variants: 16
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.040 Biomarker group BEFREE J chain and MEF2B are highly sensitive and specific markers of NLPHL versus CHL; are particularly useful in highlighting LP cells; and, with rare exception, are of greater utility than OCT-2 and BOB.1 in differentiating CHL from NLPHL and other large B-cell lymphomas. 28851661 2017
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.040 AlteredExpression group BEFREE The transformed HSs showed partial retention of their prior B-cell lymphomas' signatures, including expression of OCT2 in both cases and expression of BCL6 and enhanced expression of BCL2 in case 2. 20331331 2010
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.040 AlteredExpression group BEFREE However, it differs from other aggressive B-cell lymphomas in that it shows defective Ig production despite the expression of Oct-2, BOB.1, and PU.1 transcription factors, and a lack of IgV(H) gene crippling mutations. 15202521 2003
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.040 AlteredExpression group BEFREE However, it differs from other aggressive B-cell lymphomas in that it shows defective immunoglobulin production despite the expression of OCT-2, BOB.1, and PU.1 transcription factors and the lack of IgV(H) gene crippling mutations. 12507907 2003